Search

everythinglearnresearchcommunity

for

Search:↓

About half of people with mild alopecia areata see hair regrowth in a year, but relapses are common.

Over half of the dog skin disorders discussed have known gene variants, enabling genetic testing for diagnosis and responsible breeding.

Over half of the diabetes patients had skin issues, with fungal infections being most common.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

More than half of patients who had acromegaly surgery experienced hair loss, with varying degrees of recovery.

More than half of the women with PCOS in Southern India had Metabolic Syndrome, with large waist circumference being the most common feature.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

More than half of the young women checked had PCOS, which was linked to inactive lifestyles and poor diets.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

Up to half of adult women may experience hair loss, and doctors should use medical history, exams, and tests to find the cause and treat it.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Bimatoprost helped eyelash growth in nearly half of the patients with a type of eyelash hair loss.

Azathioprine caused side effects in over half of the Korean pediatric inflammatory bowel disease patients, requiring close monitoring.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Topical estrogens improved hair growth in about half of the patients.

PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.

Penguin Cold Caps help most patients keep at least half their hair during chemotherapy.

Scalp cooling can help prevent hair loss in about half of chemotherapy patients.

Reducing the dose of Baricitinib to 2mg still helped over half of the patients with severe scalp alopecia maintain their hair regrowth after two years.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Using a microscope during hair transplants cuts damage to follicles in half and could improve hair growth.

Home-use treatment for severe alopecia areata is as effective as office-use but costs half as much.

Post-COVID symptoms are common, affecting over half of the participants.

Baricitinib effectively treats alopecia areata, with over half of patients improving after 52 weeks.

Melanoma survivors are more likely to use sunscreen and seek shade than others, but less than half often use sunscreen and avoid the sun, and some still use tanning beds.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Using more minoxidil solution can lead to better hair growth, but people often use only half the recommended amount. Education and motivation can improve results.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.